Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva
With 190 live customers and 14 top 20 biopharma commitments, Vault CRM is the fastest path to AI PLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly and...
Covered in this story
What has happened since
- Veeva Systems is up 18.0% since this was published, 27 days ago.
- Amgen is up 7.0% since this was published, 27 days ago.
- Biogen is up 7.5% since this was published, 27 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Veeva Systems
- Wells Fargo: $265 → $330 by Sep 2027 · Overweight via Investing.com
- Piper Sandler: $282 → $320 by Aug 2027 · Overweight via Investing.com
- Stifel: $282 → $300 by Aug 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $VEEV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Veeva Systems →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.